Unit 2 Flashcards
goals of AED therapy (4)
reduce # of seizures
limit ADRs
return to normal ADL(ex driving)
improve quality of life
First-line monotherapy treatment for seizures (gen tonic-clonic, focal, or TBI)
Hydantoins: Phenytoin and Fosphenytoin
Class of seizures not to use hydantoins
gen myoclonic or absence
they can exacerbate symptoms
Phenytoin/Fosphenytoin therapeutic serum concentration
10-20mcg/ml
Phenytoin/Fosphenytoin contraindications
heart block, sinus bradycardia
Carbamazepine (tegretol) class
anticonvulsant
Carbamazepine (tegretol) is used for what seizure types?
focal onset (1st line) and generalized tonic-clonic
Carbamazepine (tegretol) therapeutic range
4-12mg/L
goals of care for status epilepticus (3)
- control SE within 60min (ASAP)
- use of benzo + AED
- supportive measures (airway mgmt, IV access, hemodynamic monitoring, ID underlying cause)
considerations for febrile seizures in peds (2)
-educated parents on the importance of fever control
-do not need AEDs
geriatric considerations related to seizures/meds
-risk of drug toxicity due to
decreased drug clearance and metabolism
considerations for women with a seizure disorder
-most AEDs are preg category C or D
-discuss pregnancy status and desires in women of childbearing age
patient education for seizures (6)
- avoid sleep deprivation (can lower seizure threshold)
- excess alcohol (can lower threshold)
- avoid heavy machinery or working from heights (risk of self harm if seizure occurs)
- never swim alone
- most sports are ok
- driving
T/F: PA providers are mandated reporters of seizures
true–> must report to DOT who will further assess the situation and see if the patient can continue to drive
3 serious side effects of macrolide antibiotics used for CAP
- QTC prolongation
- LFT abnormalities
- GI upset
sinusitis treatment (6)
intranasal steroids
augmentin
clindamycin
cephalosporins
doxycycline
fluoroquinolones
first line treatment for sinusitis
amoxicillin/augmentin after 7 days unless severe
when to use augmentin for sinusitis
if pt at high risk for infection from amoxicillin resistant pathogen
antibiotic to prescribe for sinusitis in a patient with PCN allergy
doxycycline
moxi/levofloxacin
clindamycin
considerations when using antihistamines
caution in elderly- confusion, constipation, dizziness, dry mouth, urinary retention, sedation
on beers list
considerations when using 2nd gen antihistamines (2)
ineffective for cough and may induce dryness causing worsening congestion
caution in renal and hepatic impairment
2 first gen antihistamines
benadryl
chlorpheniramine
considerations when using 1st gen antihistamines
drowsiness/sedation
contraindicated in breastfeeding
considerations for benadryl (5)
caution in:
asthma
CV disease
Increased IOP
BPH
thyroid dysfunction
considerations for chlorpheriniamine (4)
caution in:
narrow-angle glaucoma
bladder neck obstruction
BPH
avoid in newborns (SIDS)
3 2nd gen antihistamines
fexofenadine (allegra)
loratadine (claritin)
cetirizine (zyrtec)
2 intranasal antihistamines
azelastine
olopatadine
MOA of nasal decongestants
sympathomimetic agents that stimulate alpha and beta receptors causing vasoconstriction
4 contraindications of nasal decongestants
narrow-angle glaucoma
uncontrolled HTN
CAD
recent use of MAOIs
8 SE of nasal decongestants
HTN
Tachycardia
palpitations
insomnia
tremors
urinary retention (caution with BPH)
GI upset
dizziness
2 topical nasal decongestants
oxymetazoline
phenylephrine
education with topical nasal decongestants
no more than 2-3 days d/t rhinititis medicamentosa (rebound congestion)
education with oral decongestant x2
don’t crush or chew
give at least 2 hrs before bed
patho of acute bronchitis
infection of the bronchial tree
cause of acute bronchitis
90% viruses
10% bacterial
hallmark sign on acute bronchitis
moist productive cough
treatment of acute bronchitis
antitussives
expectorants
antibiotics
antivirals
antitussive drugs
benzonatate
dextromethorphan
cough meds with codeine or hydrocodone for severe cough
expectorant drug
guaifenesin
when to use antibiotics for acute bronchitis (4)
hx of COPD
high fever
cough over 4-6 days
65 y/o + with comorbidity (CAD, DM)
when to use antivirals for acute bronchitis
flu A or B+
which antibiotic for acute bronchitis from H influenzae
amox. or augmentin
which antibiotic for acute bronchitis from m catarrhalis
augmentin
which antibiotic for acute bronchitis from m pneumoniae
macrolide
which antibiotic for acute bronchitis from b pertussis
macrolide
treatment of CAP in patients without comorbidities
Amoxicillin 1 g TID OR
Doxycycline 100mg BID OR
azithromycin OR
clarithromycin 500mg BID
treatment of CAP in patients WITH comorbidities
amox + macrolide
cephalosporin + marcolide OR doxy
fluroquinolone monotherapy
3 considerations when prescribing tamiflu
within 48 hours onset
can be used for prophylaxis for up to 6 weeks during community outbreak
dosage adjustment with reduced kidney function (not recommended in ESRD)
theophylline adverse events (6)
Tachyarrhythmias
restlessness
insomnia
N/V
GERD
seizures
indication for leukotriene modifiers
allergies and asthma
3 drugs that are leukotriene modifiers
montelukast
zafirlukast
zileuton
age for montelukast
2+
age for zafirlukast
7+
age for zileuton
12+
montelukast SE
BLACK BOX serious behavior and mood changes
zafirlukast SE
pharyngitis, headache, rhinitis, gastritis
zafirlukast considerations
metabolized by CYP450
rare liver failure
monitor LFTs q2-3 months
zileuton considerations
metabolized by CYP450
monitor LFTs before, monthly for 3 months, then q2-3 months
zileuton SE
dyspepsia
abd pain
nausea
SAMA mechanism of action
short acting muscarinic antagonist
blocks acetylcholine at muscarinic receptors, decreasing cAMP which relaxes airway smooth muscle and increases bronchial ciliary activity, therefore decreasing mucous secretions
GOLD group D
- daily LABA/LAMA
- daily ICS/LABA
- daily ICS/LABA/LAMA, (can add) theophylline, phosphodiesterase 4 inhibitor, macrolide abx, OR ICS/LAMA/LABA/roflumilast
13 LABA serious SE
paradoxical bronchospasm
asthma exac
laryngospasm
hypersensitivity
anaphylaxis
HTN
HoTN
angina
cardiac arrest
arrhythmia
hypokalemia
hyperglycemia
BLACK BOX : asthma related death
namenda MOA
NaMenDA
blocks activation and overstimulation of NMDA receptor during glutamate abundance which inhibits neuronal degeneration that would otherwise result
Goal of drug therapy for AD
maintain and maximize the patient’s functional ability, quality of life, and independence for as long as possible while minimizing adverse events and cost